Challenges in Managing Patients with Hereditary Cancer at Gynecological Services
Table 1
Demographics of patients with hereditary cancer treated in our gynecological services department between 2012 and 2018.
Case no.
Genetic diagnosis
Cancer
Family history
Gynecological management
Age at diagnosis
Pathogenic mutation
Mutation point
Refseq ID
dbSNP rs no.
HBOC
1
20s
BRCA2
c.(7435 + 1_7436-1)_(7805 + 1_7806-1)dup
NM_000059.3
NA
Breast
Surveillance
2
30s
BRCA2
c.188T > A
NM_007294.3
rs80357086
Breast
Breast cancer, mother
Surveillance
3
30s
BRCA2
c.5576_5579delTTAA (p.Ile1859Lysfs)
NM_000059.3
rs80359520
Breast
Surveillance
4
30s
BRCA2
p.S1882X
NM_000059.3
NA
Breast
Surveillance
5
30s
BRCA1
c.5154G > A (p.W1718X)
NM_007294.3
rs80357239
Breast
Breast cancer, mother
RRSO (7 months after genetic diagnosis)
6
40s
BRCA2
c.2T > G (p.M1R)
NM_000059.3
rs80358547
None
Breast cancer, mother (BRCA2, case 14)
RRSO (6 months after genetic diagnosis)
7
40s
BRCA1
c.3122C > G (p.Ser1041Ter)
NM_007294
rs397509035
Breast
Bilateral breast cancer, mother Breast cancer, aunt
Surveillance
8
50s
BRCA1
Not available
—
—
Ovarian
Breast cancer, sister
Surveillance
9
50s
BRCA2
c.9117G > A (p.P3039P)
NM_000059.3
rs28897756
Bilateral breast Gastric
Breast cancer, maternal side Ovarian cancer, many relatives
RRSO (7 months after genetic diagnosis)
10
50s
BRCA2
c.5574_5577delAATT (p.Ile1859Lsyfs3)
NM_000059
rs80359520
Breast Sigmoid colon
Sigmoid colon cancer, father Gastric cancer, aunt Breast and colon cancer, paternal grandmother
Surveillance
11
50s
BRCA2
c.5645C > A (p.Ser1882Ter)
NM_000059
rs80358785
Breast
Ovarian cancer, mother
RRSO (4 months after genetic diagnosis)
12
50s
BRCA2
c.5645C > A (p.Ser1883Ter)
NM_000059
rs80358785
Breast
Breast and ovarian cancer, mother
RRSO (3 months after genetic diagnosis)
13
60s
BRCA2
c.4085delA
NM_000059.3
rs431825315
Breast
Breast cancer, father Breast and ovarian cancer, sister
RRSO (8 months after genetic diagnosis)
14
60s
BRCA1
c.2T > G (p.M1R)
NM_000059.3
rs80358547
Breast
Breast cancer, mother and sister Ovarian cancer, grandmother and aunt
RRSO (8 months after genetic diagnosis)
15
60s
BRCA1
c.3122C > G (p.Ser1041Ter)
NM_007294
rs397509035
Breast
Breast cancer, sister Breast cancer, daughter (case 7)
BSO scheduled for ovarian cyst
Lynch syndrome
16
20s
MSH2
p.Q130X
NM_000251.2
rs1060501989
Colon
Unknown
Surveillance
17
20s
MSH6
c.3663delGAinsT
NA
NA
None
Colon, endometrial, ovarian cancer, mother (MSH6)
Surveillance
18
20s
MLH1
c.381_543del (p.Ala128Trpfs8)
NM_000249.3
NA
None
Colon cancer, father (MLH1)
Surveillance
19
30s
MLH1
c.306+1G > A (p.K70_Q102del)
NM_0000249
rs267607734
Endometrial Breast
Breast, ovarian, colon cancer, mother
MPA
20
40s
MLH1
g.IVS3+1G > A
NA
NA
Sigmoid colon AEH, ovarian
Colon cancer, father (MLH1) and grandmother Colon and endometrial cancer, sister
TAH+BSO
21
70s
Not disclosed
Breast Colon Endometrial
TAH
Cowden syndrome
22
20s
PTEN
c.1026+1G > A
NM_000314
rs786201041
Bilateral breast Thyroid AEH
Father (PTEN)
D&C
23
70s
Clinical diagnosis
Breast Thyroid
Bladder cancer, father Gastric and endometrial cancer, sister
Surveillance
Peutz–Jeghers syndrome
24
Teen
Clinical diagnosis
In house
Gastric
Surveillance
25
50s
Clinical diagnosis
Others
None
Surveillance
HBOC: hereditary breast and ovarian cancer; RRSO: risk-reducing salpingo-oophorectomy; TNBC: triple negative breast cancer; AEH: atypical endometrial hyperplasia; TAH: total abdominal hysterectomy; BSO: bilateral salpingo-oophorectomy; D&C: dilatation and curettage; MPA: medroxyprogesterone acetate; PTEN: phosphatase and tensin homolog; and BRCA: breast cancer susceptibility gene.